Dodge & Cox Cuts Stock Holdings in BioMarin Pharmaceutical Inc.

Institutional investor reduces position in biotech company by 2.8%

Mar. 14, 2026 at 8:09am

Got story updates? Submit your updates here. ›

Dodge & Cox, a major institutional investor, has reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 2.8% in the third quarter, according to a recent SEC filing. The firm now owns approximately 7.64% of the biotechnology company's outstanding shares, valued at $795 million.

Why it matters

BioMarin Pharmaceutical is a prominent biotech firm focused on developing therapies for rare genetic and metabolic disorders. Institutional investors like Dodge & Cox closely monitor and adjust their positions in biotech companies as part of their broader investment strategies, so this reduction in holdings could signal a shift in market sentiment around BioMarin.

The details

In its 13F filing, Dodge & Cox reported selling 421,509 shares of BioMarin Pharmaceutical during the third quarter, lowering its total position to 14,686,801 shares. The firm remains one of BioMarin's largest institutional shareholders, but the 2.8% reduction suggests it may be taking a more cautious stance on the company's prospects in the near term.

  • Dodge & Cox reduced its BioMarin Pharmaceutical holdings in the 3rd quarter of 2026.

The players

Dodge & Cox

An institutional investment management firm that owns a significant stake in BioMarin Pharmaceutical.

BioMarin Pharmaceutical Inc.

A biopharmaceutical company specializing in the development and commercialization of therapies for rare genetic and metabolic diseases.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Dodge & Cox's BioMarin Pharmaceutical holdings suggests the investment firm may have a more cautious outlook on the biotech company's near-term prospects, though it remains a major shareholder. Investors will likely watch for any further shifts in institutional ownership of BioMarin as an indicator of broader market sentiment around the company.